[Federal Register Volume 60, Number 206 (Wednesday, October 25, 1995)]
[Notices]
[Page 54750]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-26381]
-----------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Issuer Delisting; Notice of Application to Withdraw From Listing
and Registration (U.S. Diagnostic Labs, Inc., Common Stock, $.001 Par
Value); File No. 1-13392
October 19, 1995.
U.S. Diagnostic Labs, Inc. (``Company'') has filed an application
with the Securities and Exchange Commission (``Commission''), pursuant
to Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and
Rule 12d2-2(d) promulgated thereunder, to withdraw the above specified
security (``Security'') from listing and registration on the Boston
Stock Exchange, Inc. (``BSE'').
The reasons alleged in the application for withdrawing the Security
from listing and registration include the following:
According to the Company, it is delisting the Security from the BSE
as soon as practicable after October 6, 1995 because, commencing
October 1995, the Security will be listed for quotation on the Nasdaq
National Market System (``Nasdaq/NMS'') and the rules of the Nasdaq/NMS
and the BSE do not permit a security to be listed on both the BSE and
the Nasdaq/NMS. The Security is also currently traded on the Nasdaq
SmallCap Market.
Any interested person may, on or before November 9, 1995, submit by
letter to the Secretary of the Securities and Exchange Commission, 450
Fifth Street, NW., Washington, DC 20549, facts bearing upon whether the
application has been made in accordance with the rules of the BSE and
what terms, if any, should be imposed by the Commission for the
protection of investors. The Commission, based on the information
submitted to it, will issue an order granting the application after the
date mentioned above, unless the Commission determines to order a
hearing on the matter.
For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 95-26381 Filed 10-24-95; 8:45 am]
BILLING CODE 8010-01-M
